Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Keng Khoo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Respirology Case Reports|October 6, 2025
The Case for Autoantibody Screening in Stone Benchtop WorkersTiffany Lin, Jun Keng Khoo, Ryan Hoy
Journal of Clinical Medicine|December 13, 2016
Bronchiectasis in the Last Five Years: New DevelopmentsJun Keng Khoo, Victoria Venning, Conroy Wong, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 31, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary FibrosisJun Keng Khoo, A Bruce Montgomery, Kelly L Otto, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Respirology Case Reports|October 6, 2025
The Case for Autoantibody Screening in Stone Benchtop WorkersTiffany Lin, Jun Keng Khoo, Ryan Hoy
Journal of Clinical Medicine|December 13, 2016
Bronchiectasis in the Last Five Years: New DevelopmentsJun Keng Khoo, Victoria Venning, Conroy Wong, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 31, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary FibrosisJun Keng Khoo, A Bruce Montgomery, Kelly L Otto, et al.
Pageof 1